BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6802650)

  • 1. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G; Delwaide P; Bijvoet OL; Franchimont P
    Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Vega E; Mautalen C; Roldán EJ; Pérez Lloret A
    Drugs Exp Clin Res; 1994; 20(3):103-8. PubMed ID: 7956716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
    Cantrill JA; Buckler HM; Anderson DC
    Ann Rheum Dis; 1986 Dec; 45(12):1012-8. PubMed ID: 3813665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S; Massie JD; Postlethwaite AE; Palmieri GM
    Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D; Jaeger P; Gobelet C; Jacquet AF; Burckhardt P
    Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T; Karmali R; Gillet C; François D; Fuss M
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P; Lioté F; Kuntz D
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract]   [Full Text] [Related]  

  • 14. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
    Adami S; Salvagno G; Guarrera G; Montesanti F; Garavelli S; Rosini S; Lo Cascio V
    Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Dewis P; Prasad BK; Anderson DC; Willets S
    Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 19. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K; Merry P; Scott DG
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Mautalen CA; Gonzalez D; Ghiringhelli G
    Bone; 1985; 6(6):429-32. PubMed ID: 4096879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.